PRKN and Parkinson disease: According to these data, the mtDNA mutation in MT-COXI described in PARK2-PD cells, in agreement with the low protein expression described in [39], might have an impact on the development of the Parkinsonism, as in this case CIV may be decreased in amount and availability to interact with CI for the proper operation of substrate channeling.